Publications in collaboration with researchers from Hospital Universitario 12 de Octubre (14)

2021

  1. Paliperidone Reversion of Maternal Immune Activation-Induced Changes on Brain Serotonin and Kynurenine Pathways

    Frontiers in Pharmacology, Vol. 12

2019

  1. Therapeutic targeting of HER2–CB 2 R heteromers in HER2-positive breast cancer

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 116, Núm. 9, pp. 3863-3872

  2. Erratum: Therapeutic targeting of HER2-CB2R heteromers in HER2-positive breast cancer (Proceedings of the National Academy of Sciences of the United States of America (2019) 116 (3863–3872) DOI: 10.1073/pnas.1815034116)

    Proceedings of the National Academy of Sciences of the United States of America

2018

  1. Intracellular inflammatory and antioxidant pathways in postmortem frontal cortex of subjects with major depression: Effect of antidepressants

    Journal of Neuroinflammation, Vol. 15, Núm. 1

  2. Intranasal administration of TAT-conjugated lipid nanocarriers loading GDNF for Parkinson’s disease

    Molecular Neurobiology, Vol. 55, Núm. 1, pp. 145-155

2017

  1. Paliperidone reverts Toll-like receptor 3 signaling pathway activation and cognitive deficits in a maternal immune activation mouse model of schizophrenia

    Neuropharmacology, Vol. 116, pp. 196-207

2016

  1. Activation of the orphan receptor GPR55 by lysophosphatidylinositol promotes metastasis in triple-negative breast cancer

    Oncotarget, Vol. 7, Núm. 30, pp. 47565-47575

  2. Evidence of activation of the Toll-like receptor-4 proinflammatory pathway in patients with schizophrenia

    Journal of Psychiatry and Neuroscience, Vol. 41, Núm. 3, pp. E46-E55

2005

  1. Neurotransmitter amino acid in cerebrospinal fluid of patients with dementia with Lewy bodies

    Journal of Neural Transmission, Vol. 112, Núm. 4, pp. 557-563

  2. Time course of opioid and cannabinoid gene transcription alterations induced by repeated administration with fluoxetine in the rat brain

    Neuropharmacology, Vol. 49, Núm. 5, pp. 618-626

  3. κ- and δ-opioid receptor functional activities are increased in the caudate putamen of cannabinoid CB1 receptor knockout mice

    European Journal of Neuroscience, Vol. 22, Núm. 8, pp. 2106-2110

2004

  1. Impaired action of anxiolytic drugs in mice deficient in cannabinoid CB1 receptors

    Neuropharmacology, Vol. 46, Núm. 7, pp. 966-973

  2. Role of endocannabinoid system in mental diseases

    Neurotoxicity Research, Vol. 6, Núm. 3, pp. 213-224

2002

  1. Cerebrospinal fluid and plasma concentrations of nitric oxide metabolites are increased in dementia with Lewy bodies

    Neuroscience Letters, Vol. 333, Núm. 2, pp. 151-153